Kuano is delighted to welcome Augustin Amour to the company. Gus will collaborate as a consultant, supporting senior management in our enzymatic franchises. Gus has been with GSK for the past 24 years. There, he led laboratory and project teams in R&D. With expertise in immunology and molecular pharmacology, particularly in enzyme inhibitors, he has contributed to over 50 publications and patents. Gus steers industry engagement with academia as the chair of the Biochemical Society's Industry Advisory Panel and advises the EU-OPENSCREEN consortium, underscoring his leadership in drug discovery and his commitment to biotechnological collaboration. Collaborating with Kuano brings Gus back to his Cambridge roots, where he undertook a postdoc after earning a PhD in biochemistry in Paris.
